Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05256771 · ClinicalTrials.gov registry record · NA
Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.
A NA study of Muscle Tone Increased and Fat Reduction, sponsored by Venus Concept.
- Active
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 3
- Study locations
NCT05256771: Active NA study of Muscle Tone Increased and Fat Reduction, sponsored by Venus Concept.
NCT05256771 is a NA study of Muscle Tone Increased and Fat Reduction that is active but no longer recruiting, run by Venus Concept. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05256771, a NA study of Muscle Tone Increased and Fat Reduction, is active but no longer recruiting, sponsored by Venus Concept.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 3
- Study locations
Study Summary
Multi-center, three-arm, randomized, evaluator-blinded study of electrical muscle stimulation (EMS) and/or 1064 nm diode laser, pulsed electromagnetic field (PEMF) and vacuum assisted radio frequency (RF) using the Venus Bliss Max for fat reduction, body contouring and aesthetic improvement.
Primary Outcome
Physician board-certified dermatologist to evaluate contour improvement per the Global Aesthetic Improvement Scale (GAIS), with scores in order of 'most improved' to 'worse': Most improved (score of 5); Much improved (score of 4); Improved (score of 3); No change (score of 2); Worse (score of 1).
Conditions Studied
Interventions
- DEVICE EMS
- DEVICE 1064 nm diode laser
- DEVICE RF/PEMF
Study Locations (3)
California
- Scripps Clinical Research - General Medicine - San Diego
New Jersey
- Schweiger Dermatology Group - Hackensack
Tennessee
- Tennessee Clinical Research Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the registry record for NCT05256771 still lists
NCT05256771 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Muscle Tone Increased appearing as the primary indexed condition, and to 3 interventions - of which EMS is the first listed.
NCT05256771 reports a single indexed study location in California, New Jersey, Tennessee.
Frequently Asked Questions
What is clinical trial NCT05256771 about?
NCT05256771 is a clinical study titled "Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.". Multi-center, three-arm, randomized, evaluator-blinded study of electrical muscle stimulation (EMS) and/or 1064 nm diode laser, pulsed electromagnetic field (PEMF) and vacuum assisted radio frequency (RF) using the Venus Bliss Max for fat reduction, body contouring and aesthetic improvement.
What is the current status of trial NCT05256771?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2021-11-01. Estimated completion is 2025-09-30.
What conditions does trial NCT05256771 study?
This clinical trial studies the following conditions: Muscle Tone Increased, Fat Reduction.
What interventions are being tested in trial NCT05256771?
The interventions under investigation include: EMS (DEVICE), 1064 nm diode laser (DEVICE), RF/PEMF (DEVICE).
Who is sponsoring clinical trial NCT05256771?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05256771 being conducted?
This trial has 3 study locations across California, New Jersey, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Tone Increased
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05256771's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI